US Patent Issued to Dr. Falk Pharma on Nov. 18 for "Pharmaceutical formulation for the treatment of inflammatory changes to the rectum" (German Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,191, issued on Nov. 18, was assigned to Dr. Falk Pharma GmbH (Freiburg, Germany).

"Pharmaceutical formulation for the treatment of inflammatory changes to the rectum" was invented by Rudolf Wilhelm (Bischweier, Germany), Markus Prols (Freiburg/Breisgau, Germany), Roland Greinwald (Kenzingen, Germany) and Ralf Mohrbacher (Freiburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a storage-stable pharmaceutical formulation for rectal administration, containing budesonide or a pharmaceutically compatible salt or derivative thereof, and at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of...